224 related articles for article (PubMed ID: 4826495)
1. Combination chemotherapy: considerations for design and analysis.
Lloyd HH
Cancer Chemother Rep 2; 1974 Mar; 4(1):157-65. PubMed ID: 4826495
[No Abstract] [Full Text] [Related]
2. Experimental models and their clinical correlations.
Carter SK; Goldin A
Natl Cancer Inst Monogr; 1977 Mar; (45):63-74. PubMed ID: 927496
[No Abstract] [Full Text] [Related]
3. Planning combined therapy--the interaction of experimental and clinical studies.
Carter SK
Cancer Chemother Rep 2; 1974 Mar; 4(1):3-11. PubMed ID: 4826498
[No Abstract] [Full Text] [Related]
4. Statistical designs for experiments in combination therapy.
Miller I
Cancer Chemother Rep 2; 1974 Mar; 4(1):151-6. PubMed ID: 4826494
[No Abstract] [Full Text] [Related]
5. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XV.
Leiter J; Abbott BJ; Bourke AR; Schepartz SA; Wodinsky I
Cancer Res; 1963 Sep; 23(8 Pt 2):1483-729. PubMed ID: 5878214
[No Abstract] [Full Text] [Related]
6. Screening, the cornerstone of chemotherapy.
Schabel FM
Cancer Chemother Rep 2; 1972 Nov; 3(1):309-13. PubMed ID: 4660733
[No Abstract] [Full Text] [Related]
7. Biochemical aspects of drug combinations.
Brockman RW
Cancer Chemother Rep 2; 1974 Mar; 4(1):115-29. PubMed ID: 4135108
[No Abstract] [Full Text] [Related]
8. Experimental approach for the search of effective drug combination in cancer chemotherapy.
Bello JL; Kariev NI; Mainardi JV; Betancourt M; Lage A; Barroso MC; Alfonso L
Neoplasma; 1982; 29(1):65-71. PubMed ID: 7070556
[TBL] [Abstract][Full Text] [Related]
9. ICRF-187 in clinical oncology.
Poster DS; Penta JS; Bruno S; Macdonald JS
Cancer Clin Trials; 1981; 4(2):143-6. PubMed ID: 6788388
[TBL] [Abstract][Full Text] [Related]
10. Rationale of chemotherapeutic adjuvant treatment.
Goldin A
Arch Geschwulstforsch; 1978; 48(7):627-35. PubMed ID: 736743
[No Abstract] [Full Text] [Related]
11. Design and evaluation of combination chemotherapy trials in experimental animal tumor systems.
Corbett TH; Griswold DP; Wolpert MK; Venditti JM; Schabel FM
Cancer Treat Rep; 1979 May; 63(5):799-801. PubMed ID: 455319
[No Abstract] [Full Text] [Related]
12. [Experimental basis of combination chemotherapy in the treatment of acute leukemia (author's transl)].
Hoshino A
Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):731-9. PubMed ID: 4480565
[No Abstract] [Full Text] [Related]
13. Biochemical rationales for the selection of combinations of chemotherapeutic agents.
Bono VH
Cancer Chemother Rep 2; 1974 Mar; 4(1):131-6. PubMed ID: 4826492
[No Abstract] [Full Text] [Related]
14. The historical development of cancer chemotherapy.
Burchenal JH
Semin Oncol; 1977 Jun; 4(2):135-46. PubMed ID: 327552
[No Abstract] [Full Text] [Related]
15. Rationale of combination chemotherapy based on preclinical experiments.
Goldin A
Cancer Chemother Rep 3; 1973 Mar; 4(2):189-98. PubMed ID: 4580857
[No Abstract] [Full Text] [Related]
16. Esters of chlorohydroxyacetone in chemotherapy of murine tumors.
Babiarz-Tracy P; McCarthy D; Simon P; Burlingham WJ; Fondy TP
Cancer Res; 1980 Sep; 40(9):3274-80. PubMed ID: 7427941
[No Abstract] [Full Text] [Related]
17. Combination chemotherapy--theory and practice.
Capizzi RL; Keiser LW; Sartorelli AC
Semin Oncol; 1977 Jun; 4(2):227-53. PubMed ID: 327555
[No Abstract] [Full Text] [Related]
18. Use of mathematical models for the evaluation of two- and three-drug combination chemotherapy in murine tumor models.
Fichtner I; Steinhoff G
Cancer Treat Rep; 1983; 67(7-8):621-9. PubMed ID: 6871880
[TBL] [Abstract][Full Text] [Related]
19. An outline of cancer chemotherapy.
Connors TA
Rev Roum Inframicrobiol; 1971; 8(3):135-51. PubMed ID: 5152643
[No Abstract] [Full Text] [Related]
20. Screening data from the Caner Chemotherapy National Service Center Screening Laboratories. XXIX.
Leiter J; Abbott BJ; Schepartz SA
Cancer Res; 1965 Dec; 25(11 Pt 2):1779-2061. PubMed ID: 5856668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
